Life-saving medical supplies delivered by drones
Silicon-Valley based Zipline International Inc. is responsible for the blood supply for the entire western half of Rwanda. Zipline uses intelligent drones, designed and engineered with Siemens PLM software, to overcome the country’s challenging infrastructure and air drop medical supplies to doctors and hospitals on demand, delivering with 100 percent success.
Even though the U.S. has a more substantial road infrastructure, rural areas could still benefit from this life-saving technology.
Watch the video
Technology to help American communities
A recent index from U.S. News and World report ranked America 17th in Quality of Life.
Among America’s domestic challenges, the country now spends significantly more on healthcare than every other high-income nation but has lower life expectancy and worse overall health.
Additionally, infrastructure needed to support growing, high-density population centers isn’t keeping pace with demand. The return of Americans to cities is creating a variety of challenges, including traffic congestion, lack of energy productivity, and environmental problems.
To improve healthcare, Siemens is focused on providing lifesaving health technology and driving breakthrough medical innovations.
To develop the smart cities of the future, Siemens is pioneering intelligent infrastructure.
Detecting Zika – early and accurately
Siemens Healthineers’ Molecular Diagnostics team is advancing innovation in the world of molecular testing – including the fight against the Zika virus.
Zika has been linked to a number of harmful impacts – even birth defects such as microcephaly.
Siemens invested in research and development to innovate Zika detection technology, supporting physicians in their efforts to innovate an assay for the qualitative detection of the Zika virus in RNA (ribonucleic acid). Last year its new molecular testing kit for the Zika virus was granted an Emergency Use Authorization (EUA) by the U.S. Food and Drug Administration (FDA).*
*The VERSANT® Zika RNA 1.0 Assay (kPCR) Kit has been authorized by FDA under an EUA for use by authorized Laboratories only for the detection of RNA from Zika virus and diagnosis of Zika virus infection, not for any other viruses or pathogens. This test has not been FDA cleared or approved. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Building the City of the Future
By 2050, two-thirds of the world’s population will live in cities. With current U.S. infrastructure earning a D+ grade by The American Society of Civil Engineers, the U.S. needs to improve its infrastructure with smart solutions to ensure the economic success and longevity of cities across America. The answer is building smarter infrastructure.
In Seattle, Siemens is integrating traffic management systems across the city’s urban areas, enhancing real-time traffic alert and control. Using software, Seattle will be able to link traffic planning and control systems in order to take better advantage of its existing road infrastructure, lessen the impact of major traffic incidents, better manage traffic around large events such as football games and reduce overall congestion.